clinical trials, techniques

The cofounder of the EQUATOR Network devoted his career to boosting transparency and improving the quality of clinical research.

Cell implants, gene therapy, even optogenetics are making headway in clinical trials to treat various forms of blindness.  

There’s a right way and a wrong way to boost the statistical sensitivity of this type of clinical studies.

New research shows that low-intensity fields can inhibit cancer cell proliferation.

Statistician Paul Meier, who championed the random assignment of patients to treatment groups in clinical trials, changed the way the researchers test experimental drugs.

A UK panel puts forth guidelines for research that use experimental animals harboring human cells and tissues.

Drug therapies tailored to the DNA profiles of individual patients could change the face of medicine, but such treatments aren't commonly used in the clinic.

New compounds are showing promise in targeting subpopulations of cancer stem cells.